| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |